Showing results (1821-1830 of 1,931) with videos related to

Sort By:
Pageof 194
The Laryngoscope|September 24, 2017
Balloon dilation of the eustachian tube for dilatory dysfunction: A randomized controlled trialDennis Poe, Vijay Anand, Marc Dean, et al.
Frontiers in Public Health|April 4, 2025
HLS19-DIGI - a new instrument for measuring digital health literacy: development, validation and associations with determinants and health outcomes in 13 countriesDiane Levin-Zamir, Stephan Van den Broucke, Éva Bíró, et al.
Ebiomedicine|October 4, 2018
Fisetin is a senotherapeutic that extends health and lifespanMatthew J Yousefzadeh, Yi Zhu, Sara J McGowan, et al.
AIDS (London, England)|November 22, 2024
SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in AfricaEmmanuelle Papot, Tamara Tovar-Sanchez, Joana Woods, et al.
Immunobiology|October 9, 2022
IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19Alejandro Hernández-Solis, Azmavet M Güemes-González, Ximena Ruiz-Gómez, et al.
Prostaglandins & Other Lipid Mediators|November 15, 2019
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-DiabetesRupak Shivakoti, Jesmond Dalli, Dileep Kadam, et al.
Cancer Discovery|November 14, 2022
OncoLoop: A Network-Based Precision Cancer Medicine FrameworkAlessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Global Health Action|October 27, 2023
Neonatal outcomes according to different degrees of maternal morbidity: cross-sectional evidence from the Perinatal Information System (SIP) of the CLAP networkMercedes Colomar, Bremen de Mucio, Claudio Sosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial ResultsAdi Diab, Helen Gogas, Shahneen Sandhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Pageof 194